[1]
Y. Vitruk, “Evaluation of response to tyrosine kinase inhibitors in renal cell carcinoma patients based on expression of miR-99b, -144, -210, -222, -302а and -377 in tumor tissue”, Exp. oncol., vol. 43, no. 2, pp. 98–103, May 2023.